Abstract
Immunoadjuvants have major effects on the immune responses in vaccine formulations. Many specific adjuvants have been studied, including mineral salts, emulsions, cytokines, non-ionic block copolymers, carbohydrate polymers, muramyl dipeptides, and saponin-based adjuvants. Here, we focus on quillaic acid–containing saponin-based adjuvants and their mechanisms of action. Interestingly, when analyzing the adjuvants capable of forming immune-stimulating complexes, one of the characteristics shared by the majority of them is the presence of quillaic acid as the aglycone. This suggests that quillaic acid might be a strategic molecule for immunoadjuvant activity and a powerful candidate in the development of novel adjuvants.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
